Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma
Matthay, K.K.
Bone Marrow Transplantation 18(Suppl 3): S21-S24
1996
ISSN/ISBN: 0268-3369 PMID: 8971402 Document Number: 455756
Current results suggest that purged autologous bone marrow transplant may improve outcome for some subsets of high risk neuroblastoma, but the risk of relapse is still high.
Document emailed within 1 workday
Related Documents
Ahmed, T.; Ciavarella, D.; Feldman, E.; Ascensao, J.; Hussain, F.; Engelking, C.; Gingrich, S.; Mittelman, A.; Coleman, M.; Arlin, Z.A. 1989: High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease Leukemia 3(1): 19-22Locasciulli, A.; Alberti, A.; de Bock, R.; Cordonnier, C.; Einsele, H.; Engelhard, D.; Grundy, J.; Reusser, P.; Ribaud, P.; Ljungman, P. 1994: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party Bone Marrow Transplantation 14(5): 833-837
Endo, M.; Tanosaki, R. 1995: Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(12): 1762-1770
Kriz, J.; Saudek, F.; Girman, P.; Novota, P. 2004: Enhancement of rat islet tolerance with bone marrow transplantation using a non-myeloablative procedure II: failure despite the presence of lymphocyte microchimerism in the fully allogeneic Lewis/Brown-Norway model International Journal of Tissue Reactions 26(3-4): 75-83
Seeger, R.C.; Villablanca, J.G.; Matthay, K.K.; Harris, R.; Moss, T.J.; Feig, S.A.; Selch, M.; Ramsay, N.; Reynolds, C.P. 1991: Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma Progress in Clinical and Biological Research 366: 527-533
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Kapelushnik, J.; Nagler, A.; Or, R.; Naparstek, E.; Cividalli, G.; Aker, M.; Mehta, J.; Mumcuoglu, M.; Slavin, S. 1993: Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging Transplantation Proceedings 25(3): 2375-2376
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Frappaz, D.; Maritaz, O.; Favrot, M.C.; Philip, I.; Bernard, J.L.; Bailly, C.; Gentilhomme, O.; Gentet, J.C.; Zucker, J.M.; Bouffet, E. 1987: Detection of residual cells contaminating the bone marrow in neuroblastoma. Apropos of 80 bone marrow evaluations Archives Francaises de Pediatrie 44(9): 771-778
León-Rodríguez, E.; Sosa Sánchez, R.; Gómez, E.; Ochoa Sosa, C. 1993: Bone marrow transplantation in aplastic anemia. Experience at a Mexican institution. Bone marrow transplantation group of the Salvador Zubirán National Institute of Nutrition Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 45(6): 559-564
Gassmann, W.; von Kolszynski, M.; Wottge, H.U.; Müller-Ruchholtz, W. 1987: Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation Transplantation Proceedings 19(1 Part 3): 2687-2688
Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470
Kamani, N.; August, C.S.; Bunin, N.; Leahey, A.; Bayever, E.; Goldwein, J.; Zusman, J.; Evans, A.E.; Angio, G.D. 1996: A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma Bone Marrow Transplantation 17(6): 911-916
Nakayama, H.; Okamura, J.; Ikuno, Y.; Shigeno, K.; Tasaka, H. 1992: Isolated renal relapse after bone marrow transplantation in childhood leukemia. Bone Marrow Transplantation Team Bone Marrow Transplantation 10(2): 195
Duhamel, G.; Gorin, N.C.; Douay, L.; Najman, A.; Stachowiak, J. 1982: Bone marrow repopulation after heavy chemotherapy and autologous bone marrow transplantation. Monitoring with biopsies and marrow culture on agar La Nouvelle Presse Medicale 11(11): 833-836
Martino, R.; Brunet, S.; García, A.; Sureda, A.; Soler, J.; Martínez, C.; Domingo-Albós, A.; Baiget, M. 1995: Various patterns of chimerism after allogeneic bone marrow transplantation for advanced chronic lymphocytic leukemia Bone Marrow Transplantation 16(6): 783-786
De Witte, T.; Zwaan, F.; Hermans, J.; Vernant, J.; Kolb, H.; Vossen, J.; Lönnqvist, B.; Beelen, D.; Ferrant, A.; Gmür, J. 1989: Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Bone Marrow Transplantation 4(Suppl 3): 38-39
Michon, J.; Négrier, S.; Coze, C.; Mathiot, C.; Frappaz, D.; Oskam, R.; Pacquement, H.; Quintana, E.; Bouffet, E.; Bernard, J.L. 1994: Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. a Lyon-Marseille-Curie-east of France Group Study Progress in Clinical and Biological Research 385: 293-300